TrueVision Systems
Executives
4Board of Directors
1TrueVision Systems Management Team
4 Team Members
TrueVision Systems has 4 executives. TrueVision Systems's current Chief Executive Officer is Forrest Fleming.
Name | Work History | Title | Status |
|---|---|---|---|
Forrest Fleming | Chief Executive Officer | Current | |
Name | Forrest Fleming | |||
|---|---|---|---|---|
Work History | ||||
Title | Chief Executive Officer | |||
Status | Current |
This profile has not been claimed.
Highlight your management team’s expertise.
TrueVision Systems Board of Director
1 Board of directors
TrueVision Systems has 1 board of directors, including Frederick Gluck.
Name | Firm | Work History | Other Seats |
|---|---|---|---|
Frederick Gluck | Mr. Frederick W. Gluck has served as a director of the Company since February 1998. He is currently a non-executive Chairman of the Board of CytomX Therapeutics, LLC and Cynvenio Biosystems LLC, privately-held medical technology companies. Mr. Gluck is a former managing partner of McKinsey & Company, Inc., an international management consulting firm. From 1967 to 1995, he served with McKinsey and from 1988 to 1994 he led the firm as its Managing Director, when he retired to join Bechtel Group, Inc., an engineering, construction and project management company, where he served as Vice Chairman and Director. Mr. Gluck retired from Bechtel in July 1998. He rejoined McKinsey as a consultant in 1998 and continued in that role until July 2003, when he retired. | TrueVision Systems |
Name | Frederick Gluck |
|---|---|
Firm | |
Work History | Mr. Frederick W. Gluck has served as a director of the Company since February 1998. He is currently a non-executive Chairman of the Board of CytomX Therapeutics, LLC and Cynvenio Biosystems LLC, privately-held medical technology companies. Mr. Gluck is a former managing partner of McKinsey & Company, Inc., an international management consulting firm. From 1967 to 1995, he served with McKinsey and from 1988 to 1994 he led the firm as its Managing Director, when he retired to join Bechtel Group, Inc., an engineering, construction and project management company, where he served as Vice Chairman and Director. Mr. Gluck retired from Bechtel in July 1998. He rejoined McKinsey as a consultant in 1998 and continued in that role until July 2003, when he retired. |
Other Seats | TrueVision Systems |
Compare TrueVision Systems to Competitors
Spineworks Medical, Inc. designs and manufactures medical devices for spinal surgery.
iBalance, Inc. is developing an improved method for completing an orthopedic surgical procedure called high tibial osteotomy. The company aims to provide the surgical tools and implant for this knee malalignment corrective surgery.
Diamas Coats offers biocompatible coating services to companies selling body implants, surgical cutters and personal grooming razors
Focal develops, manufactures and commercializes synthetic, absorbable, liquid surgical sealants based on the company's polymer technology. The company's FocalSeal-L and FocalSeal-S surgical sealant products are currently being developed for use inside the body to seal leaks resulting from lung, neurological, cardiovascular and gastrointestinal surgery.
TransCorp develops and commercializes minimally invasive surgical instruments and implants for neurosurgical and orthopedic applications.
ES Vascular Ltd. developed first ever surgical stapling devices for endovascular surgery. These devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions. The company is currently developing three product lines for open AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first products are anticipated to enter the market in 2008.nCompany Snapshotn Started in 2000 in Israel by Prof. Shifrin together with group of engineers and leading vascular surgeons from the US and Europe;n Developed a ever vascular stapling technology for stapling synthetic grafts to the aortan Developed endovascular devices for EVAR and SFA procedures
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.